Steven Mapula, MD
Plastic and Reconstructive Surgery · Fort Worth, TXNPI 1861623704
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,416 of the $14,233 with a category attached, or 66.2%. 28 manufacturers reported payments, led by AbbVie at 44.3% of the total. 2025 is the largest year on record at $6,442, more than ten times the $445 reported in 2019.
Across 180 payments — averaging $79.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Johnson & Johnson$3K
- TELA Bio, Inc.$1K
- Musculoskeletal Transplant Foundation Inc.$844
- Integra Lifesciences Corporation$703
- Davol Inc.$254
- plus $2K from 22 others
Across 32 payments — averaging $6880.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Avita Medical Americas, LLC$192K
- Axogen$28K
What the payments were for
- Consulting fees$2,45017%
- Travel & lodging$2,36617%
- Food & beverage$9,41666%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $6,301 |
| Johnson & Johnson | 11 | $3,196 |
| TELA Bio, Inc. | 39 | $1,323 |
| Musculoskeletal Transplant Foundation Inc. | 8 | $844 |
| Integra Lifesciences Corporation | 21 | $703 |
| Davol Inc. | 3 | $254 |
| Avita Medical Americas, LLC | 4 | $247 |
| Acera Surgical, Inc. | 6 | $182 |
| Sientra, Inc. | 2 | $180 |
| Axogen | 2 | $176 |
| Smith+Nephew | 7 | $125 |
| Medical Device Business Services, Inc. | 1 | $125 |
| Stryker | 1 | $88 |
| Derma Sciences, Inc. | 1 | $81 |
| Mimedx Group, Inc. | 2 | $72 |
| Vertex | 3 | $72 |
| Polynovo North America LLC | 2 | $41 |
| Atricure, Inc. | 1 | $38 |
| Guard Medical Inc. | 1 | $29 |
| Access Pro Medical, LLC | 1 | $26 |
| Mentor Worldwide LLC | 1 | $25 |
| Resmed Corp | 1 | $18 |
| Biocircuit Technologies Inc | 1 | $18 |
| Medtronic | 1 | $18 |
| Aesculap, Inc. | 1 | $17 |
| RTI Surgical, Inc | 1 | $13 |
| Tactile Systems Technology Inc | 1 | $12 |
| Checkpoint Surgical, Inc | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$5,421
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$2,044
- REVOLVE$1,914
- ALLODERM$716
- STRATAFIX$366
- INTEGRA$353
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$266
- Megadyne$234
- OviTex 2S$173
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$170
- AxoGuard Nerve Connector$154
- AxoGuard Nerve Protector$154
- Phasix Mesh$152
- RECELL$149
- DERMABOND$120
- INTEGRA DERMAL REGENERATION TEMPLATE$118
- PRIMATRIX$118
- VISTASEAL$114
- DERMABOND PRINEO$114
How this compares
$14,233 in reported general payments places this provider in the 85th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 43 | $2,089 |
| Gabapentin | 24 | $573 |
| Ondansetron OdtOndansetron | 41 | $490 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $406 |
| Tramadol Hcl | 14 | $54 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Fort Worth
- Robert AndersonFort Worth$75K
- Srikanth KurapatiFort Worth$44K
- Theodorus KurkjianFort Worth$14K
- David LavineFort Worth$13K
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Joshua LemmonRichardson$118K
- Patrick GarveyHouston$117K
- Rukmini RednamHouston$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.